Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
作者信息
Curcio Daniel, Fernández Francisco, Jones Ronald N, Ferraro Mary Jane, Reller L Barth, Schreckenberger Paul C, Sader Helio S
出版信息
J Clin Microbiol. 2007 Jun;45(6):2095; author reply 2095-6. doi: 10.1128/JCM.00107-07.
Abstract
摘要
相似文献
1
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.不动杆菌属的替加环素纸片扩散法药敏试验折点：临床视角
J Clin Microbiol. 2007 Jun;45(6):2095; author reply 2095-6. doi: 10.1128/JCM.00107-07.
2
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.针对不动杆菌属的替加环素纸片扩散药敏结果的多中心研究
J Clin Microbiol. 2007 Jan;45(1):227-30. doi: 10.1128/JCM.01588-06. Epub 2006 Nov 8.
3
The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used.不动杆菌属对替加环素的敏感性可能因所采用的方法而异。
Int J Infect Dis. 2010 Sep;14 Suppl 3:e351-2. doi: 10.1016/j.ijid.2009.08.015. Epub 2009 Dec 23.
4
Impact of test methodology, media type and ion content on the susceptibility of Acinetobacter spp. to tigecycline.检测方法、培养基类型和离子含量对不动杆菌属细菌对替加环素敏感性的影响。
J Antimicrob Chemother. 2014 Jun;69(6):1710-1. doi: 10.1093/jac/dkt546. Epub 2014 Jan 30.
5
In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.替加环素对韩国分离出的耐黏菌素不动杆菌属菌株的体外活性。
Int J Antimicrob Agents. 2009 Mar;33(3):289-90. doi: 10.1016/j.ijantimicag.2008.09.005. Epub 2008 Dec 16.
6
Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey.土耳其多药耐药鲍曼不动杆菌分离株的替加环素药敏性。
Pol J Microbiol. 2013;62(3):295-8.
7
Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.不动杆菌属对替加环素的敏感性：全球视角
J Antimicrob Chemother. 2007 Aug;60(2):449-50. doi: 10.1093/jac/dkm202. Epub 2007 Jun 7.
8
Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.关于《多重耐药鲍曼不动杆菌对替加环素的高耐药性》的评论
J Antimicrob Chemother. 2007 Jul;60(1):177-8; author reply 178-9. doi: 10.1093/jac/dkm142. Epub 2007 May 11.
9
Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.评论：不同的穆勒-欣顿琼脂对不动杆菌属替加环素纸片扩散药敏试验的影响
J Antimicrob Chemother. 2008 Nov;62(5):1166-7. doi: 10.1093/jac/dkn328. Epub 2008 Aug 9.
10
Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.科威特医院患者分离出的不动杆菌属中替加环素和黏菌素耐药性的出现。
J Chemother. 2011 Feb;23(1):13-6. doi: 10.1179/joc.2011.23.1.13.
引用本文的文献
1
In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran.替加环素和黏菌素对伊朗德黑兰和阿巴斯港医院鲍曼不动杆菌临床分离株的体外活性
Electron Physician. 2014 Jul 1;6(3):919-24. doi: 10.14661/2014.919-924. eCollection 2014 Jul-Sep.
2
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.替加环素治疗多重耐药（包括耐碳青霉烯类）鲍曼不动杆菌感染：科学证据综述
J Antimicrob Chemother. 2008 Jul;62(1):45-55. doi: 10.1093/jac/dkn165. Epub 2008 Apr 24.
本文引用的文献
1
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.针对不动杆菌属的替加环素纸片扩散药敏结果的多中心研究
J Clin Microbiol. 2007 Jan;45(1):227-30. doi: 10.1128/JCM.01588-06. Epub 2006 Nov 8.
2
Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas.美洲鲍曼不动杆菌菌株中PER-2和VEB-1a的出现。
Antimicrob Agents Chemother. 2006 Sep;50(9):3222-4. doi: 10.1128/AAC.00284-06.
3
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.黏菌素：用于多重耐药革兰氏阴性菌感染的再度兴起的抗生素。
Lancet Infect Dis. 2006 Sep;6(9):589-601. doi: 10.1016/S1473-3099(06)70580-1.
4
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia.呼吸机相关性肺炎治疗起始的适宜性与延迟情况
Eur Respir J. 2006 Jan;27(1):158-64. doi: 10.1183/09031936.06.00049105.
5
Tigecycline.替加环素
J Antimicrob Chemother. 2005 Sep;56(3):470-80. doi: 10.1093/jac/dki248. Epub 2005 Jul 22.
Zotero 插件